Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
Details for Australian Patent Application No. 2005216075 (hide)
International Classifications
Event Publications
24 August 2006 PCT application entered the National Phase
PCT publication WO2005/081847 Priority application(s): WO2005/081847
21 September 2006 Assignment before Grant
Hybridon, Inc. The application has been assigned to Idera Pharmaceuticals, Inc.
10 March 2011 Application Accepted
Published as AU-B-2005216075
7 July 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser